Company intelligence / Profile preview

Agilis Robotics

Hong Kong/Shenzhen, China/Hong Kong SARagilisrobotics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Agilis Robotics has developed a next-generation miniaturized and flexible robotic system designed to enhance dexterity and access for minimally invasive endoluminal surgeries. The technology aims to improve outcomes in early-stage cancer removal and other complex procedures within the GI and urinary tracts. Clinical integration with existing hospital workflows has been emphasized, but no published pivotal trial results are available yet.

Therapeutic areas: OncologyMetabolic DisordersGastroenterologyWomen's Health
Modalities: DeviceRobotic surgical system
Industry: Surgical Medical Devices

Partnerships

Notable academic partnership with University of Hong Kong as investor/supporter.

Beyond the preview

Go deeper on Agilis Robotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agilis Robotics.

Explore the full profile